FDA Approves Novel Chinese Drug Pimicotinib for Tenosynovial Giant Cell Tumor (TGCT)
On November 10, 2026, the U.S. Food and Drug Administration (FDA) approved pimicotinib (PIMJETMI®) for…
Articles
Lymphoma CAR-T Therapy IM19 Approved in China for Relapsed or Refractory LBCL
On November 5, 2026, China’s National Medical Products Administration (NMPA) approved lymphoma CAR-T therapy IM19,…
20 FAQs About Medical Treatment in China for Foreigners
This article covers 20 FAQs about medical treatment in China for foreigners, offering practical guidance…
Medical Tourism in China: A Complete Guide for International Patients (2026)
This comprehensive guide to medical tourism in China covers major medical cities, leading hospitals, popular…
Latest Innovative Drugs in China 2026
This article lists the latest innovative drugs in China 2026, including indications, pharmaceutical companies, and…
Bayer’s Asundexian Approved in China: A Novel FXIa Inhibitor for Stroke Prevention
On October 26, 2026, China’s NMPA approved Bayer’s novel coagulation factor XIa (FXIa) inhibitor, asundexian,…
China Rare Disease Drug Catalog: Drug List, Indications, and Approval Information
This China rare disease drug catalog covers rare disease medicines available in China as of…
New Drug Batoclimab for Myasthenia Gravis Approved in China, Advancing FcRn-Targeted Therapy
On October 22, 2026, China’s NMPA official website showed the approval of batoclimab injection for…
How to Choose Oral Nutritional Supplements for Cancer Patients: Types, Protein Needs & Usage Guide
Malnutrition is a common concern among people with cancer. It may be associated with reduced…
Targeted Drugs for Thyroid Cancer by Cancer Type: Common Agents and Molecular Targets
Key Takeaways Thyroid cancer is a common endocrine malignancy. For some patients with advanced, metastatic…